What Unipharm does

Unipharm is a privately held international pharmaceuticals company founded in 1992 and headquartered in New York, USA. The company manufactures and markets over-the-counter (OTC) drugs and nutritional supplements, primarily serving mass-market consumers across Eurasian markets. Its product portfolio includes MELAXEN (melatonin-based sleep aid), DETRIMAX (Vitamin D3 supplements in adult and pediatric formulations), LACTOBALANCE (multiprobiotic supplements with 9 bacterial strains delivering 3 billion CFU per capsule), GRIPPEX (paracetamol/pseudoephedrine/dextromethorphan cold and flu medication), and additional supplement lines (MULTIMAX, ARTHRON, VITRUM) addressing joint, vision, active lifestyle, beauty, and children's nutrition use-cases. Manufacturing is carried out in established facilities in the United States and European Union under GMP guidelines, with raw materials sourced from GMP-certified vendors. The company is FDA-registered and operates quality control processes including raw material testing, microbiological analysis, physical and quantitative analysis, and government-authority testing in each target market.

The business model is a consumer goods distribution play rather than a drug development enterprise. Unipharm monetizes through one-time product sales of its branded OTC and supplement lines via retail and pharmacy channels across nine countries (USA, Ireland, Poland, Ukraine, Georgia, Kazakhstan, Moldova, Azerbaijan, and Uzbekistan), supported by a wholly-owned subsidiary and representative office structure. Its customer segmentation is horizontal, with general consumer health as the primary segment and secondary use-case segments spanning children's nutrition, active lifestyle, beauty/wellness, joint/bone support, vision health, and seasonal illness prevention. Pricing is not publicly disclosed, and the company relies on its corporate website plus country-specific local sites (e.g., unipharm.pl, unipharm.ua, unipharm.ge, unipharm.kz) as the primary marketing and customer-interaction channel. Distribution in the US is supported by a partnership with Ameripharma Labs.

From a corporate-structure perspective, Unipharm, Inc. is the US parent, with Unipharm Laboratories Limited (Dublin, Ireland) serving as the European operating entity and Unipharm Sp. z o.o. (Warsaw, Poland) handling Polish operations; the remaining countries are served via wholly-owned representative offices. The company has no disclosed institutional investors, no funding rounds, and no M&A activity in the source data, consistent with a founder-driven, cash-flow-funded private business. Headcount is reported in the 101-250 range, and the firm has maintained continuous operations for over 25 years with an emphasis on brand-led market leadership in its Eurasian core markets and a documented charitable-donation program spanning NGOs in multiple geographies.

Name

Unipharm

Legal name

UNIPHARM, INC.

Website

https://unipharmus.com

Company type

Private

Founded year

1992

Operating status

Operating

Headcount range

101–250 employees

Short description

Unipharm is a privately held New York-based pharmaceuticals company that manufactures and distributes OTC drugs and nutritional supplements (MELAXEN, DETRIMAX, LACTOBALANCE, GRIPPEX) through retail and pharmacy channels across nine countries, primarily serving Eurasian consumer health markets.

Ownership category

akta.pro rank

Product category

OTC Pharmaceuticals

NAICS

Drugs and Druggists' Sundries Merchant Wholesalers (424210)

SIC

Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Sleep, Stress & Mood OTC (Sleep Aids, Melatonin OTC, Calm/Stress Relief) (CRADAMAJ)

akta.pro secondary industries

OTC Pain Relief & Fever (Analgesics, Anti-inflammatory, Topical Pain Relief) (CRADAMAC), Sleep, Stress & Mood Support (HLAIADAG), OTC & Consumer Health Distributors (HLAIAJAC)

Keywords

• OTC pharmaceuticals
• Nutritional supplements
• Vitamin D supplements
• Probiotic supplements
• Cold and flu remedies

Headquarters

HQ city

New York

HQ country

United States

HQ region

North America

Offices9 records

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D

Revenue model

1. OTC Drug Sales: Sale of over-the-counter medications including Grippex (cold/flu relief) and Melaxen (melatonin sleep aid). Products are sold through retail and pharmacy channels globally.
2. Nutritional Supplement Sales: Sale of vitamin and mineral nutritional supplements including Detrimax (Vitamin D), Lactobalance (probiotics), and Multimax product lines for various health needs.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels3 records

Core offering

Unipharm manufactures and markets over-the-counter (OTC) drugs and nutritional supplements sold through retail and pharmacy channels. Core offerings include melatonin-based sleep aids (MELAXEN), Vitamin D3 supplements (DETRIMAX), multiprobiotic supplements (LACTOBALANCE), and cold/flu relief medication (GRIPPEX). Products are manufactured in the USA and EU under GMP guidelines and distributed across Eurasian markets.

Product overview

Unipharm is a pharmaceutical and nutritional supplement company offering a portfolio of over-the-counter products. The core product lineup includes: MELAXEN® 3 mg (melatonin-based sleep supplement), DETRIMAX® and DETRIMAX® BABY (Vitamin D3 supplements for adults and infants), LACTOBALANCE® and LACTOBALANCE® KIDS (multiprobiotic supplements with 9 probiotic strains for adults and children), and GRIPPEX® (cold and flu relief medication). Products are manufactured in the USA and European Union following GMP guidelines, with the company being FDA registered.

Differentiator

Problem solved

Functional benefit

Brands

• MELAXEN®: Melatonin supplement for sleep support, 3mg tablets
• DETRIMAX®
• DETRIMAX® BABY
• LACTOBALANCE®
• LACTOBALANCE® KIDS
• GRIPPEX®
• MULTIMAX®
• ARTHRON®
• VITRUM®

Products and services

• MELAXEN® 3 mg Sleep aid supplement containing melatonin (3 mg tablets), a hormone that regulates the normal sleep/wake cycle. Supports healthy sleep cycles in individuals suffering from occasional sleeplessness, particularly when adjusting to staggered work cycles or jet lag. Marketed to adult consumers.
• DETRIMAX® Vitamin D3 (cholecalciferol) supplement available in tablet form with dosages of 1000 IU, 2000 IU, 4000 IU, and 5000 IU. Supports bone, dental, and immune health in adults.
• DETRIMAX® BABY Vitamin D3 supplement specifically formulated for infants and young children. Contains 200 IU per drop in a 30 ml bottle with pump dispenser. Supports bone and dental tissue development and immune function.
• LACTOBALANCE® Multiprobiotic supplement containing a balanced combination of 9 strains of probiotic microorganisms (bifidobacteria and lactobacilli) producing at least 3 billion CFU per capsule. Strains are resistant to gastric juice, digestive enzymes, and bile acids with high adhesion to intestinal mucosa. Supports restoration of normal intestinal microflora and immune function.
• LACTOBALANCE® KIDS Children's multiprobiotic supplement with 9 probiotic strains producing 3 billion CFU per capsule, produced in Japan. Formulated to restore and normalize intestinal microflora in children from 3 years of age. Available as 14 chewable tablets with vanilla taste.
• GRIPPEX® Over-the-counter cold and flu medication combining 325 mg paracetamol, 30 mg pseudoephedrine, and 10 mg dextromethorphan. Temporarily relieves symptoms of the common cold including runny nose, sneezing, cough, headache, nasal congestion, and fever. For adults and children over 12 years old.

Quantifiable outcome

• 37% decline in daily melatonin output between ages 20-70 addressed by MELAXEN
• +1 more outcomes

Named customers5 records

Segments7 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

One partnership is on record.

• AmeripharmaminorOthersAmeripharma Labs is shown as a partner/distributor with logo displayed on Unipharm website. Ameripharma Labs logo is linked from the main navigation.

Scale indicators3 records

Recent moves5 records

Expansion highlights4 records

Direct peers

• Pharmstandard: Pharmstandard is the largest Russian pharmaceutical company by retail sales, with a portfolio of OTC drugs, pharmaceuticals, and supplements sold across CIS markets. It is the closest direct peer to Unipharm in terms of product categories (OTC, vitamins, probiotics), Eurasian geographic focus, and brand-driven distribution model.
• OTCPharm: OTCPharm is a leading Russian OTC distributor and brand owner, owned by Pharmstandard, specializing in cold/flu, vitamins, and consumer health products across Russia and CIS. Comparable to Unipharm in product mix, distribution channels, and regional concentration.
• Evalar: Evalar is one of the largest Russian manufacturers of dietary supplements and OTC natural health products, with vertically integrated cultivation, manufacturing, and pharmacy distribution. Directly comparable to Unipharm in probiotic, vitamin, and supplement categories and in Eurasian market positioning.
• Natrol: Natrol is a US-based dietary supplement manufacturer best known for its melatonin sleep products and broader vitamin/supplement portfolio, now part of Aurobindo Pharma. Highly comparable to Unipharm's MELAXEN sleep brand and LACTOBALANCE probiotic positioning, but operating primarily in the US retail channel.
• NOW Foods: NOW Foods is a US-based family-owned manufacturer and distributor of dietary supplements, vitamins, and natural health products including melatonin and probiotic lines. Comparable to Unipharm in product categories and GMP manufacturing, but with stronger US direct-to-consumer and e-commerce presence.

Broad incumbents

• Bayer Consumer Health: Bayer Consumer Health operates a global OTC and supplement portfolio including brands like Berocca, Elevit, and Canesten. Overlaps with Unipharm's vitamins, cold/flu, and general wellness categories but at significantly larger scale, broader geographic reach, and stronger marketing budgets.
• Perrigo Company: Perrigo is a global OTC consumer healthcare and generic pharmaceutical company with deep presence in store-brand and branded OTC categories. Comparable to Unipharm in OTC manufacturing capabilities and retail distribution, but operating at substantially larger scale across the US, Europe, and emerging markets.
• Sanofi Consumer Healthcare: Sanofi's Consumer Healthcare division markets global OTC brands including sleep, vitamin, and cold/flu products across all major geographies. Comparable to Unipharm in core OTC categories but competes at global scale with vastly greater R&D and marketing resources.
• Church & Dwight: Church & Dwight owns a portfolio of consumer health brands including vitamin and supplement lines (e.g., Vitafusion, First Response). Overlaps with Unipharm in vitamins and consumer health OTC, with broader US mass-market distribution and significantly larger marketing spend.
• Haleon: Haleon (formerly GSK Consumer Healthcare) is a global consumer health company with major OTC and supplement brands across pain relief, vitamins, and oral health. Operates at global scale in categories overlapping with Unipharm's MELAXEN, DETRIMAX, and GRIPPEX portfolios.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/unipharm-inc.

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries8 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Unipharm